KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
July 07, 2025 08:00 ET | Source: KALA BIO, Inc. ARLINGTON, Mass.,…
Persistent Achieves Top Rankings for the Second Year in a Row in Extel’s Asia Executive Team Survey
Recognized under multiple categories, including Best CEO, Company Board of Directors, Overall…
